Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
AUTHORS
Nuotio-Antar
AMAlli M ,
Hachey
DL David L ,
Hasty
AH Alyssa H .
American journal of physiology. Endocrinology and metabolism. 2007 12 ; 293(6).
E1517-28
- PMID: 17878220[PubMed].